These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36566797)

  • 41. Membrane-Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram-Negative Superbugs.
    Hwang J; Barman S; Gao R; Yang X; O'Malley A; Nagarkatti P; Nagarkatti M; Chruszcz M; Tang C
    Adv Healthc Mater; 2023 Dec; 12(31):e2301764. PubMed ID: 37565371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
    Pagès JM; Amaral L; Fanning S
    Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bacterial resistance to antibiotics: active efflux and reduced uptake.
    Kumar A; Schweizer HP
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1486-513. PubMed ID: 15939505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breaching the Barrier: Genome-Wide Investigation into the Role of a Primary Amine in Promoting E. coli Outer-Membrane Passage and Growth Inhibition by Ampicillin.
    Maher C; Maharjan R; Sullivan G; Cain AK; Hassan KA
    Microbiol Spectr; 2022 Dec; 10(6):e0359322. PubMed ID: 36409154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance.
    Gootz TD
    Biochem Pharmacol; 2006 Mar; 71(7):1073-84. PubMed ID: 16359640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
    Blair JM; Richmond GE; Piddock LJ
    Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efflux-mediated drug resistance in bacteria.
    Li XZ; Nikaido H
    Drugs; 2004; 64(2):159-204. PubMed ID: 14717618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
    Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
    Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of antibiotic efflux in Gram-negative bacteria.
    Zgurskaya HI; Krishnamoorthy G; Tikhonova EB; Lau SY; Stratton KL
    Front Biosci; 2003 Sep; 8():s862-73. PubMed ID: 12957812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small-Molecular Adjuvants with Weak Membrane Perturbation Potentiate Antibiotics against Gram-Negative Superbugs.
    Dhanda G; Mukherjee R; Basak D; Haldar J
    ACS Infect Dis; 2022 May; 8(5):1086-1097. PubMed ID: 35404568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.
    Aeschlimann JR
    Pharmacotherapy; 2003 Jul; 23(7):916-24. PubMed ID: 12885104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
    Klobucar K; Jardine E; Farha MA; MacKinnon MR; Fragis M; Nkonge B; Bhando T; Borrillo L; Tsai CN; Johnson JW; Coombes BK; Magolan J; Brown ED
    ACS Infect Dis; 2022 Oct; 8(10):2187-2197. PubMed ID: 36098580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.
    Marshall RL; Lloyd GS; Lawler AJ; Element SJ; Kaur J; Ciusa ML; Ricci V; Tschumi A; Kühne H; Alderwick LJ; Piddock LJV
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A small molecule that disrupts S. Typhimurium membrane voltage without cell lysis reduces bacterial colonization of mice.
    Dombach JL; Quintana JL; Allgood SC; Nagy TA; Gustafson DL; Detweiler CS
    PLoS Pathog; 2022 Jun; 18(6):e1010606. PubMed ID: 35687608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microscopic Approach to Intrinsic Antibiotic Resistance.
    Manrique PD; Gnanakaran S
    J Phys Chem B; 2021 Apr; 125(12):3114-3118. PubMed ID: 33754733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
    Lyu Y; Yang X; Goswami S; Gorityala BK; Idowu T; Domalaon R; Zhanel GG; Shan A; Schweizer F
    J Med Chem; 2017 May; 60(9):3684-3702. PubMed ID: 28409644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.